-+ 0.00%
-+ 0.00%
-+ 0.00%

Eikon Therapeutics Q3 EPS $(1.59) Beats $(1.68) Estimate

Benzinga·11/12/2026 11:35:31
Listen to the news
Eikon Therapeutics (NASDAQ:EIKN) reported quarterly losses of $(1.59) per share which beat the analyst consensus estimate of $(1.68) by 5.36 percent. This is a 93.44 percent increase over losses of $(24.24) per share from the same period last year.